Selected article for: "blood spleen and high level"

Author: Meng, Fandan; Ren, Yudong; Suo, Siqingaowa; Sun, Xuejiao; Li, Xunliang; Li, Pengchong; Yang, Wei; Li, Guangxing; Li, Lu; Schwegmann-Wessels, Christel; Herrler, Georg; Ren, Xiaofeng
Title: Evaluation on the Efficacy and Immunogenicity of Recombinant DNA Plasmids Expressing Spike Genes from Porcine Transmissible Gastroenteritis Virus and Porcine Epidemic Diarrhea Virus
  • Document date: 2013_3_19
  • ID: 081o2zmd_45
    Snippet: Most exogenous proteins and even inactivated pathogens are internalized and processed via the endolysosomal pathway; the resulting degradation of proteins yields peptides that are associated with MHC-II molecules. They not only may stimulate antibody responses but also the production of helper T cells, which are necessary for the specificity of antibodies and CTLs production. Activated CD 4 + T cells can be classified into at least two subgroups,.....
    Document: Most exogenous proteins and even inactivated pathogens are internalized and processed via the endolysosomal pathway; the resulting degradation of proteins yields peptides that are associated with MHC-II molecules. They not only may stimulate antibody responses but also the production of helper T cells, which are necessary for the specificity of antibodies and CTLs production. Activated CD 4 + T cells can be classified into at least two subgroups, Th1 and Th2. The Th1-like phenotype is predominantly associated with interleukin-2 (IL-2) and interferon-c (IFN-c) [30, [43] [44] [45] [46] ; The Th2-like phenotype, characterized by increased levels of interleukin-4 (IL-4), interleukin-5 (IL-5), and interleukin-6 (IL-6), is associated with improving humoral response and mucosal immune response [21, 38] . In this study, the number of CD 4 + T lymphocytes in peripheral blood and spleen reached the peak at 42 dpi and the number of CD 4 + T cells from mice immunized with pIRES-(TGEV-S1-PEDV-S) was higher (p,0.05) than pIRES-(TGEV-S1-PEDV-S1) group. Changes in serum IFN-c and IL-4 levels in immunized mice were analyzed. The results showed that the levels of IFN-c in mice treated with DNA vaccine were significantly higher. In addition, the levels of IFN-c induced by pIRES-(TGEV-S1-PEDV-S) were higher than other groups (p,0.05). However, the levels of IL-4 in all treatment groups were fluctuant, especially, in pIRES-(TGEV-S1-PEDV-S1) and pIRES-(PEDV-S1) group the IL-4 level even much lower (P,0.05) than PBS and pIRES control. This result may be explained by the high level of IFN-c promoting the Th1 cell differentiation, at the same time, restraining the Th2 cell differentiation by down-regulating IL-4 and humoral immune response. This tendency is consistent with the IgG antibody changes in 42 dpi. Several reports also suggested that the level of antigen presentation can affect Th1/ Th2 profiles [4] .

    Search related documents:
    Co phrase search for related documents
    • antibody change and humoral immune response: 1
    • antibody change and humoral response: 1, 2
    • antibody change and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • antibody response and cell differentiation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • antibody response and ctl production: 1, 2
    • antibody response and ctl production antibody: 1, 2
    • antibody response and dna vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antibody response and exogenous protein: 1, 2
    • antibody response and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antibody response and humoral immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antibody response and humoral response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antibody response and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antibody response stimulate and immune response: 1, 2, 3
    • antigen presentation and cell differentiation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • antigen presentation and ctl production: 1
    • antigen presentation and dna vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • antigen presentation and exogenous protein: 1
    • antigen presentation and high level: 1, 2, 3
    • antigen presentation and humoral immune response: 1, 2, 3, 4, 5, 6, 7